Real Estate - REIT - Retail - NYSE - US
$ 15.62
-0.888 %
$ 819 M
Market Cap
1.15
P/E
SITE Centers is an owner and manager of open-air shopping centers that provide a highly-compelling shopping experience and merchandise mix for retail partners and consumers. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.[ Read More ]
The intrinsic value of one SITC stock under the base case scenario is HIDDEN Compared to the current market price of 15.6 USD, SITE Centers Corp. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart SITC
FINANCIALS
551 M
REVENUE
137 M
OPERATING INCOME
266 M
NET INCOME
239 M
OPERATING CASH FLOW
560 M
INVESTING CASH FLOW
-251 M
FINANCING CASH FLOW
90.8 M
REVENUE
-595 M
OPERATING INCOME
323 M
NET INCOME
36.8 M
OPERATING CASH FLOW
1.12 B
INVESTING CASH FLOW
-1.26 B
FINANCING CASH FLOW
Balance Sheet Decomposition
SITE Centers Corp.
| Current Assets | 667 M |
| Cash & Short-Term Investments | 552 M |
| Receivables | 65.6 M |
| Other Current Assets | 49.6 M |
| Non-Current Assets | 3.39 B |
| Long-Term Investments | 39.4 M |
| PP&E | 17.4 M |
| Other Non-Current Assets | 3.34 B |
| Current Liabilities | 260 M |
| Accounts Payable | 48.7 M |
| Short-Term Debt | 684 K |
| Other Current Liabilities | 210 M |
| Non-Current Liabilities | 1.63 B |
| Long-Term Debt | 1.66 B |
| Other Non-Current Liabilities | -32.7 M |
EFFICIENCY
Earnings Waterfall
SITE Centers Corp.
| Revenue | 551 M |
| Cost Of Revenue | 166 M |
| Gross Profit | 385 M |
| Operating Expenses | 263 M |
| Operating Income | 137 M |
| Other Expenses | -128 M |
| Net Income | 266 M |
RATIOS
69.92%
GROSS MARGIN
24.93%
OPERATING MARGIN
48.23%
NET MARGIN
12.21%
ROE
6.54%
ROA
3.58%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
SITE Centers Corp.
| Net Income | 266 M |
| Depreciation & Amortization | 212 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 7.63 M |
| Change in Working Capital | -20.6 M |
| Others | -237 M |
| Free Cash Flow | 239 M |
Wall Street Analysts Price Targets
SITE Centers Corp.
Wall Street analysts predict an average 1-year price target for SITC of $40.7 , with forecasts ranging from a low of $15.5 to a high of $68 .
SITC Lowest Price Target
Wall Street Target
15.5 USD
-0.77%
SITC Average Price Target
Wall Street Target
40.7 USD
160.68%
SITC Highest Price Target
Wall Street Target
68 USD
335.34%
4. DIVIDEND ANALYSIS
4.87%
DIVIDEND YIELD
48.7 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
SITE Centers Corp.
Sold
0-3 MONTHS
354 K USD 1
3-6 MONTHS
54.8 M USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
2 months ago
Aug 21, 2024
|
Sell 354 K USD
|
Fennerty Conor
EVP, CFO & Treasurer |
- 5850
|
60.54 USD |
|
3 months ago
Jul 31, 2024
|
Sell 6.62 M USD
|
Otto Alexander
Director |
- 424355
|
15.611 USD |
|
3 months ago
Aug 01, 2024
|
Sell 4.54 M USD
|
Otto Alexander
Director |
- 293874
|
15.438 USD |
|
4 months ago
Jun 27, 2024
|
Sell 4.67 M USD
|
Otto Alexander
Director |
- 327735
|
14.253 USD |
|
4 months ago
Jun 28, 2024
|
Sell 5.15 M USD
|
Otto Alexander
Director |
- 357568
|
14.395 USD |
|
4 months ago
Jun 25, 2024
|
Sell 3.28 M USD
|
Otto Alexander
Director |
- 231198
|
14.17 USD |
|
4 months ago
Jun 26, 2024
|
Sell 3.22 M USD
|
Otto Alexander
Director |
- 228042
|
14.11 USD |
|
4 months ago
Jun 21, 2024
|
Sell 3.46 M USD
|
Otto Alexander
Director |
- 240958
|
14.36 USD |
|
4 months ago
Jun 24, 2024
|
Sell 5.58 M USD
|
Otto Alexander
Director |
- 384663
|
14.5 USD |
|
5 months ago
Jun 18, 2024
|
Sell 1.19 M USD
|
Otto Alexander
Director |
- 82984
|
14.396 USD |
|
4 months ago
Jun 20, 2024
|
Sell 2.75 M USD
|
Otto Alexander
Director |
- 191167
|
14.36 USD |
|
5 months ago
Jun 14, 2024
|
Sell 2.18 M USD
|
Otto Alexander
Director |
- 149835
|
14.555 USD |
|
5 months ago
Jun 17, 2024
|
Sell 1.62 M USD
|
Otto Alexander
Director |
- 111811
|
14.509 USD |
|
5 months ago
Jun 12, 2024
|
Sell 3.57 M USD
|
Otto Alexander
Director |
- 242573
|
14.71 USD |
|
5 months ago
Jun 13, 2024
|
Sell 2.67 M USD
|
Otto Alexander
Director |
- 182383
|
14.62 USD |
|
5 months ago
Jun 10, 2024
|
Sell 1.34 M USD
|
Otto Alexander
Director |
- 91778
|
14.56 USD |
|
5 months ago
Jun 11, 2024
|
Sell 3 M USD
|
Otto Alexander
Director |
- 209076
|
14.36 USD |
|
1 year ago
Jun 16, 2023
|
Sell 159 K USD
|
Fennerty Conor
EVP, CFO & Treasurer |
- 12000
|
13.26 USD |
|
1 year ago
Dec 27, 2022
|
Sell 150 K USD
|
Cattonar John M
EVP & Chief Investment Officer |
- 11000
|
13.613 USD |
|
2 years ago
Apr 28, 2022
|
Sell 5.16 M USD
|
Lukes David R
President & CEO |
- 310797
|
16.5873 USD |
|
2 years ago
Mar 29, 2022
|
Sell 591 K USD
|
Vesy Christa A
EVP & CAO |
- 35000
|
16.879 USD |
|
2 years ago
Mar 22, 2022
|
Sell 154 K USD
|
Fennerty Conor
EVP, CFO & Treasurer |
- 9500
|
16.18 USD |
|
3 years ago
Nov 15, 2021
|
Sell 34.1 M USD
|
Otto Alexander
director, 10 percent owner: |
- 2062102
|
16.538 USD |
|
3 years ago
Nov 16, 2021
|
Sell 620 K USD
|
Otto Alexander
director, 10 percent owner: |
- 37898
|
16.362 USD |
|
3 years ago
Aug 26, 2021
|
Sell 3.9 M USD
|
Otto-Bernstein Katharina
10 percent owner |
- 250000
|
15.598 USD |
|
3 years ago
Aug 18, 2021
|
Sell 1.4 M USD
|
MACFARLANE VICTOR B
Director |
- 95497
|
14.71 USD |
|
3 years ago
May 27, 2021
|
Sell 75 K USD
|
Finne Thomas
Director |
- 5000
|
14.993 USD |
|
3 years ago
May 26, 2021
|
Sell 666 K USD
|
AHERN TERRANCE R
Director |
- 45000
|
14.8002 USD |
|
3 years ago
May 27, 2021
|
Sell 601 K USD
|
AHERN TERRANCE R
Director |
- 40000
|
15.0141 USD |
|
3 years ago
May 13, 2021
|
Sell 143 K USD
|
AHERN TERRANCE R
Director |
- 10000
|
14.2852 USD |
|
3 years ago
May 14, 2021
|
Sell 368 K USD
|
AHERN TERRANCE R
Director |
- 25200
|
14.5856 USD |
|
3 years ago
May 10, 2021
|
Sell 588 K USD
|
AHERN TERRANCE R
Director |
- 39700
|
14.8219 USD |
|
3 years ago
May 06, 2021
|
Sell 959 K USD
|
AHERN TERRANCE R
Director |
- 65907
|
14.5521 USD |
|
3 years ago
May 07, 2021
|
Sell 425 K USD
|
AHERN TERRANCE R
Director |
- 28693
|
14.8199 USD |
|
3 years ago
May 05, 2021
|
Sell 346 K USD
|
Fennerty Conor
EVP, CFO & Treasurer |
- 23717
|
14.58 USD |
|
3 years ago
Apr 26, 2021
|
Sell 123 M USD
|
Otto Alexander
director, 10 percent owner: |
- 8500000
|
14.435 USD |
|
3 years ago
Dec 30, 2020
|
Sell 373 K USD
|
Otto Alexander
director, 10 percent owner: |
- 36398
|
10.2594 USD |
|
3 years ago
Dec 28, 2020
|
Sell 1.03 M USD
|
Otto Alexander
director, 10 percent owner: |
- 100000
|
10.2844 USD |
|
3 years ago
Dec 29, 2020
|
Sell 135 K USD
|
Otto Alexander
director, 10 percent owner: |
- 13100
|
10.2947 USD |
|
3 years ago
Dec 22, 2020
|
Sell 20.3 K USD
|
Otto Alexander
director, 10 percent owner: |
- 1988
|
10.2018 USD |
|
3 years ago
Dec 23, 2020
|
Sell 1.06 M USD
|
Otto Alexander
director, 10 percent owner: |
- 103090
|
10.2736 USD |
|
3 years ago
Dec 24, 2020
|
Sell 259 K USD
|
Otto Alexander
director, 10 percent owner: |
- 25410
|
10.2069 USD |
|
3 years ago
Dec 18, 2020
|
Sell 381 K USD
|
Otto Alexander
director, 10 percent owner: |
- 36612
|
10.4051 USD |
|
3 years ago
Dec 16, 2020
|
Sell 1.49 M USD
|
Otto Alexander
director, 10 percent owner: |
- 142186
|
10.4591 USD |
|
3 years ago
Dec 17, 2020
|
Sell 1.57 M USD
|
Otto Alexander
director, 10 percent owner: |
- 150000
|
10.4548 USD |
|
3 years ago
Dec 11, 2020
|
Sell 1.22 M USD
|
Otto Alexander
director, 10 percent owner: |
- 119600
|
10.2296 USD |
|
3 years ago
Dec 14, 2020
|
Sell 2.16 M USD
|
Otto Alexander
director, 10 percent owner: |
- 211500
|
10.2255 USD |
|
3 years ago
Dec 15, 2020
|
Sell 1.55 M USD
|
Otto Alexander
director, 10 percent owner: |
- 148214
|
10.441 USD |
|
3 years ago
Dec 08, 2020
|
Sell 1.41 M USD
|
Otto Alexander
director, 10 percent owner: |
- 138203
|
10.1681 USD |
|
3 years ago
Dec 09, 2020
|
Sell 4.75 M USD
|
Otto Alexander
director, 10 percent owner: |
- 456494
|
10.3984 USD |
|
3 years ago
Dec 10, 2020
|
Sell 2.65 M USD
|
Otto Alexander
director, 10 percent owner: |
- 253500
|
10.4447 USD |
|
3 years ago
Dec 03, 2020
|
Sell 1.88 M USD
|
Otto Alexander
director, 10 percent owner: |
- 180276
|
10.4369 USD |
|
3 years ago
Dec 04, 2020
|
Sell 2.16 M USD
|
Otto Alexander
director, 10 percent owner: |
- 205002
|
10.5195 USD |
|
3 years ago
Dec 07, 2020
|
Sell 1.49 M USD
|
Otto Alexander
director, 10 percent owner: |
- 145025
|
10.294 USD |
|
4 years ago
May 04, 2020
|
Bought 110 K USD
|
Sweeney Dawn M.
Director |
+ 20000
|
5.485 USD |
|
4 years ago
Mar 19, 2020
|
Bought 97.3 K USD
|
Makinen Michael
EVP & COO |
+ 20576
|
4.73 USD |
|
4 years ago
Mar 19, 2020
|
Bought 90 K USD
|
Lukes David R
President & CEO |
+ 20000
|
4.5 USD |
|
4 years ago
Mar 19, 2020
|
Bought 50.3 K USD
|
Fennerty Conor
EVP, CFO & Treasurer |
+ 11000
|
4.576 USD |
|
4 years ago
Mar 18, 2020
|
Bought 441 K USD
|
Lukes David R
President & CEO |
+ 80000
|
5.516 USD |
|
4 years ago
Mar 19, 2020
|
Bought 24 K USD
|
Lukes David R
President & CEO |
+ 2000
|
12 USD |
|
4 years ago
Mar 19, 2020
|
Bought 24 K USD
|
Lukes David R
President & CEO |
+ 2000
|
12 USD |
|
4 years ago
Mar 19, 2020
|
Bought 107 K USD
|
AHERN TERRANCE R
Director |
+ 27000
|
3.96 USD |
|
5 years ago
Aug 30, 2019
|
Sell 12.7 K USD
|
Finne Thomas
Director |
- 500
|
25.4 USD |
|
5 years ago
Dec 31, 2018
|
Bought 165 K USD
|
Lukes David R
President & CEO |
+ 15000
|
11 USD |
|
6 years ago
Apr 03, 2018
|
Bought 15.5 K USD
|
MACFARLANE VICTOR B
Director |
+ 2115.1038
|
7.32 USD |
|
6 years ago
Jan 05, 2018
|
Bought 2.98 K USD
|
MACFARLANE VICTOR B
Director |
+ 327.9582
|
9.09 USD |
|
7 years ago
Oct 10, 2017
|
Bought 2.92 K USD
|
MACFARLANE VICTOR B
Director |
+ 318.158
|
9.18 USD |
|
7 years ago
Jul 06, 2017
|
Bought 2.86 K USD
|
MACFARLANE VICTOR B
Director |
+ 309.068
|
9.26 USD |
|
6 years ago
Jul 03, 2018
|
Bought 15.9 K USD
|
MACFARLANE VICTOR B
Director |
+ 883.9388
|
17.97 USD |
|
6 years ago
Apr 04, 2018
|
Bought 43.7 K USD
|
Lukes David R
President & CEO |
+ 5874.022
|
7.4395 USD |
|
6 years ago
Jun 29, 2018
|
Bought 3.51 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 194931
|
17.9886 USD |
|
6 years ago
Jun 28, 2018
|
Bought 7.83 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 438981
|
17.8424 USD |
|
6 years ago
Jun 26, 2018
|
Bought 11.4 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 637583
|
17.8424 USD |
|
6 years ago
Jun 25, 2018
|
Bought 13 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 729721
|
17.7996 USD |
|
6 years ago
Jun 22, 2018
|
Bought 7.09 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 394437
|
17.9794 USD |
|
6 years ago
Jun 21, 2018
|
Bought 8 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 446158
|
17.9257 USD |
|
6 years ago
Jun 20, 2018
|
Bought 685 K USD
|
Otto Alexander
director, 10 percent owner: |
+ 39422
|
17.3742 USD |
|
6 years ago
Jun 19, 2018
|
Bought 8.13 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 471062
|
17.2489 USD |
|
6 years ago
Jun 18, 2018
|
Bought 4.04 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 236237
|
17.0868 USD |
|
6 years ago
Jun 06, 2018
|
Sell 177 K USD
|
Roulston Scott D
Director |
- 10734
|
16.4686 USD |
|
6 years ago
May 15, 2018
|
Bought 2.3 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 316052
|
7.2703 USD |
|
6 years ago
May 14, 2018
|
Bought 3.71 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 500086
|
7.4124 USD |
|
6 years ago
May 11, 2018
|
Bought 1.43 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 190546
|
7.4913 USD |
|
6 years ago
May 10, 2018
|
Bought 1.61 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 214959
|
7.493 USD |
|
6 years ago
May 09, 2018
|
Bought 2.79 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 374157
|
7.4669 USD |
|
6 years ago
May 08, 2018
|
Bought 3.01 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 409188
|
7.3509 USD |
|
6 years ago
May 07, 2018
|
Bought 2.52 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 341225
|
7.3898 USD |
|
6 years ago
May 04, 2018
|
Bought 1.79 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 246662
|
7.2696 USD |
|
6 years ago
May 03, 2018
|
Bought 1.41 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 196387
|
7.1723 USD |
|
6 years ago
May 02, 2018
|
Bought 4.8 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 662341
|
7.2455 USD |
|
6 years ago
May 01, 2018
|
Bought 3.61 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 494217
|
7.3025 USD |
|
6 years ago
Apr 30, 2018
|
Bought 4.03 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 552067
|
7.2993 USD |
|
6 years ago
Apr 27, 2018
|
Bought 5.28 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 708936
|
7.4411 USD |
|
6 years ago
Apr 02, 2018
|
Bought 5.2 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 711616
|
7.3108 USD |
|
6 years ago
Mar 29, 2018
|
Bought 2.89 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 393568
|
7.3382 USD |
|
6 years ago
Mar 28, 2018
|
Bought 2.73 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 377331
|
7.2388 USD |
|
6 years ago
Mar 27, 2018
|
Bought 2.2 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 315164
|
6.9837 USD |
|
6 years ago
Mar 26, 2018
|
Bought 2.45 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 350933
|
6.9798 USD |
|
6 years ago
Mar 23, 2018
|
Bought 3.02 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 432557
|
6.9719 USD |
|
6 years ago
Mar 22, 2018
|
Bought 3.88 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 557718
|
6.9501 USD |
|
6 years ago
Feb 26, 2018
|
Bought 6 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 757558
|
7.9227 USD |
|
6 years ago
Feb 23, 2018
|
Bought 4.56 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 594000
|
7.6705 USD |
|
6 years ago
Feb 22, 2018
|
Bought 5.63 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 736569
|
7.6415 USD |
|
6 years ago
Feb 21, 2018
|
Bought 3.81 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 509373
|
7.4863 USD |
|
7 years ago
Jun 22, 2017
|
Bought 500 K USD
|
AHERN TERRANCE R
Director |
+ 59000
|
8.47 USD |
|
7 years ago
Jun 21, 2017
|
Bought 502 K USD
|
Lukes David R
President & CEO |
+ 60000
|
8.37 USD |
|
7 years ago
Jun 02, 2017
|
Bought 5.28 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 600000
|
8.8 USD |
|
7 years ago
Jun 02, 2017
|
Bought 100 K USD
|
Makinen Michael
EVP & COO |
+ 11325
|
8.83 USD |
|
7 years ago
Jun 02, 2017
|
Bought 17.4 K USD
|
Finne Thomas
Director |
+ 2000
|
8.7 USD |
|
7 years ago
May 12, 2017
|
Bought 501 K USD
|
Ostrower Matthew Louis
EVP, CFO & Treasurer |
+ 53000
|
9.46 USD |
|
7 years ago
May 12, 2017
|
Bought 1.61 M USD
|
Lukes David R
President & CEO |
+ 170000
|
9.48 USD |
|
7 years ago
May 11, 2017
|
Bought 4.7 M USD
|
Otto-Bernstein Katharina
10 percent owner |
+ 500000
|
9.3953 USD |
|
7 years ago
May 09, 2017
|
Bought 19.1 K USD
|
Finne Thomas
Director |
+ 2000
|
9.54 USD |
|
7 years ago
May 09, 2017
|
Bought 4.76 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 500000
|
9.52 USD |
|
7 years ago
Apr 28, 2017
|
Bought 5.46 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 500000
|
10.9153 USD |
|
7 years ago
Apr 28, 2017
|
Bought 11 K USD
|
Finne Thomas
Director |
+ 1000
|
11.0399 USD |
|
7 years ago
Apr 28, 2017
|
Bought 11.1 K USD
|
Finne Thomas
Director |
+ 1000
|
11.0699 USD |
|
7 years ago
Mar 23, 2017
|
Bought 51.2 K USD
|
GIDEL ROBERT H
Director |
+ 4000
|
12.8 USD |
|
7 years ago
Mar 22, 2017
|
Bought 24.9 K USD
|
Finne Thomas
Director |
+ 2000
|
12.45 USD |
|
7 years ago
Mar 09, 2017
|
Bought 26.9 K USD
|
Finne Thomas
Director |
+ 2000
|
13.47 USD |
|
7 years ago
Mar 09, 2017
|
Bought 996 K USD
|
AHERN TERRANCE R
Director |
+ 76000
|
13.106 USD |
|
7 years ago
Dec 23, 2016
|
Bought 660 K USD
|
Otto Alexander
director, 10 percent owner: |
+ 44293
|
14.8937 USD |
|
7 years ago
Dec 22, 2016
|
Bought 589 K USD
|
Otto Alexander
director, 10 percent owner: |
+ 39707
|
14.8262 USD |
|
7 years ago
Dec 15, 2016
|
Bought 1.27 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 86000
|
14.823 USD |
|
8 years ago
Nov 17, 2016
|
Bought 3.28 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 218699
|
14.981 USD |
|
8 years ago
Nov 14, 2016
|
Bought 944 K USD
|
Otto Alexander
director, 10 percent owner: |
+ 62951
|
14.9903 USD |
|
8 years ago
Nov 11, 2016
|
Bought 35.3 K USD
|
Otto Alexander
director, 10 percent owner: |
+ 2350
|
15.0223 USD |
|
8 years ago
Nov 10, 2016
|
Bought 3.21 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 216000
|
14.8837 USD |
|
8 years ago
Oct 31, 2016
|
Bought 24 K USD
|
Finne Thomas
Director |
+ 1577
|
15.2 USD |
|
8 years ago
Oct 31, 2016
|
Bought 228 K USD
|
AUGUST THOMAS F
President and CEO |
+ 15000
|
15.2199 USD |
|
8 years ago
Oct 31, 2016
|
Bought 230 K USD
|
AUGUST THOMAS F
President and CEO |
+ 15100
|
15.22 USD |
|
8 years ago
Aug 23, 2016
|
Bought 102 K USD
|
Roulston Scott D
Director |
+ 5500
|
18.607 USD |
|
8 years ago
Jul 29, 2016
|
Sell 754 K USD
|
MACFARLANE VICTOR B
Director |
- 38996
|
19.34 USD |
|
8 years ago
Jul 29, 2016
|
Sell 312 K USD
|
GIDEL ROBERT H
Director |
- 16000
|
19.5035 USD |
|
8 years ago
Jun 27, 2016
|
Sell 86.9 K USD
|
Vesy Christa A
Exec. V.P. & Chief Acct. Off. |
- 5000
|
17.38 USD |
|
8 years ago
May 05, 2016
|
Sell 521 K USD
|
Freddo Paul W
Sr. Exec. Vice President |
- 28939
|
18 USD |
|
8 years ago
Feb 17, 2016
|
Sell 48.9 K USD
|
Roulston Scott D
Director |
- 3000
|
16.3 USD |
|
9 years ago
Aug 25, 2015
|
Bought 20.6 K USD
|
GIDEL ROBERT H
Director |
+ 1300
|
15.8499 USD |
|
9 years ago
Jun 23, 2015
|
Bought 13.3 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 829071
|
16.04 USD |
|
9 years ago
Jun 22, 2015
|
Bought 2.75 M USD
|
Otto Alexander
director, 10 percent owner: |
+ 170929
|
16.09 USD |
|
9 years ago
May 28, 2015
|
Sell 18.7 K USD
|
Roulston Scott D
Director |
- 1090
|
17.1201 USD |
|
9 years ago
Apr 02, 2015
|
Sell 144 K USD
|
AHERN TERRANCE R
Director |
- 5650
|
25.48 USD |
|
9 years ago
Mar 23, 2015
|
Sell 21.1 K USD
|
Roulston Scott D
Director |
- 1100
|
19.2247 USD |
|
9 years ago
Jan 08, 2015
|
Sell 116 K USD
|
Vesy Christa A
Exec. V.P. & Chief Acct. Off. |
- 6000
|
19.3655 USD |
|
10 years ago
Nov 10, 2014
|
Sell 92.5 K USD
|
Finne Thomas
Director |
- 5000
|
18.5 USD |
|
10 years ago
Nov 06, 2014
|
Sell 475 K USD
|
HURWITZ DANIEL B
CEO |
- 25973
|
18.2843 USD |
|
10 years ago
Oct 03, 2014
|
Sell 50.2 K USD
|
Roulston Scott D
Director |
- 3000
|
16.75 USD |
|
10 years ago
Aug 12, 2014
|
Sell 266 K USD
|
Freddo Paul W
Sr. Exec. Vice President |
- 15000
|
17.75 USD |
|
10 years ago
Aug 08, 2014
|
Sell 106 M USD
|
Otto Alexander
10 percent owner |
- 6810538
|
15.5692 USD |
|
10 years ago
Aug 06, 2014
|
Sell 69.2 K USD
|
Roulston Scott D
Director |
- 4000
|
17.2918 USD |
|
10 years ago
Aug 01, 2014
|
Sell 993 K USD
|
HURWITZ DANIEL B
CEO |
- 56649
|
17.5259 USD |
|
10 years ago
May 22, 2014
|
Sell 103 K USD
|
GIDEL ROBERT H
Director |
- 6000
|
17.1001 USD |
|
10 years ago
May 13, 2014
|
Sell 458 K USD
|
MACNAB CRAIG
Director |
- 26315
|
17.3872 USD |
|
10 years ago
Apr 03, 2014
|
Sell 66.6 K USD
|
Roulston Scott D
Director |
- 4000
|
16.652 USD |
|
10 years ago
Apr 02, 2014
|
Sell 265 K USD
|
MACNAB CRAIG
Director |
- 15945
|
16.64 USD |
|
10 years ago
Mar 25, 2014
|
Sell 164 K USD
|
Freddo Paul W
Sr. Exec. Vice President |
- 10000
|
16.45 USD |
|
10 years ago
Mar 25, 2014
|
Sell 165 K USD
|
Freddo Paul W
Sr. Exec. Vice President |
- 10000
|
16.5 USD |
7. News
CBL & Associates Properties Vs. SITE Centers: Which Is The Better REIT For 2025
CBL & Associates Properties and SITE Centers are REITs focused on retail real estate, with reported occupancy rates indicating poor competitive dynamics. CBL funds a greater proportion of its capital structure with debt, but both companies have significant floating rate debt exposure. CBL is more attractively valued on an enterprise-level and AFFO multiple basis, but also reports higher administrative expenses.
seekingalpha.com
- 3 days ago
HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker
Phase 2 trial evaluating eseba-vec/pembrolizumab combination resulted in a 52% ORR in PD-L1 CPS>20 patients and encouraging PFS and OS data, supported by highly durable and tumor-specific T cell response, with good overall safety Phase 2 trial evaluating eseba-vec/pembrolizumab combination resulted in a 52% ORR in PD-L1 CPS>20 patients and encouraging PFS and OS data, supported by highly durable and tumor-specific T cell response, with good overall safety
globenewswire.com
- 5 days ago
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
Two oral presentations and multiple posters on clinical and preclinical-stage candidates to be presented at SITC, demonstrating the strength of Immatics' TCR-T PRAME franchise to target solid cancers
globenewswire.com
- 1 week ago
Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Data continues positive trend as additional patients are enrolled in 3 cohorts Vaccine was safe and well tolerated by participants in all 3 cohorts Protocol defined immune responses were exhibited in over 70% of patients A Phase 2 study evaluating the vaccine in the neoadjuvant setting is planned to commence in 2025 SAN JOSE, Calif. , Nov. 8, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced a presentation of new, updated positive data from the Phase 1 clinical trial of its breast cancer vaccine (NCT04674306) at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, being held in Houston, Texas.
prnewswire.com
- 1 week ago
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
BOSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced its poster presentation entitled “Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of a Phase 1 Trial of CTX-471, a Novel Anti-CD137 Agonist Antibody” at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting, from November 6-10, 2024 in Houston, TX.
globenewswire.com
- 1 week ago
Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT (Bifunctional SuperKine for ImmunoTherapy), engineered to deliver an anti-PD1-IL-2 Superkine (anti-PD1-IL-2 SK ) to the tumor microenvironment (TME), where it is conditionally activated by tumor-associated proteases
globenewswire.com
- 1 week ago
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
PHILADELPHIA and VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today is pleased to report preclinical data showing strong anti-cancer activity of its next generation, personalized, off-the-shelf, cell-based breast and prostate cancer immunotherapies, Bria-BRES+™ and Bria-PROS+™, respectively, during a poster session at the 2024 Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, held November 6-10, 2024, in Houston, TX.
globenewswire.com
- 1 week ago
Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that new preclinical data supporting the clinical development of its proprietary next generation antibody-drug conjugate (ADC) and innovative tetra-specific ANKET® will be presented at the SITC Annual Meeting 2024. “We are thrilled to share our latest preclinical data at the SITC Annual Meeting, highlighting the potential of IPH6501, our tetra-spe.
businesswire.com
- 1 week ago
Akeso Published Mechanism of Action for CLDN18.2/CD47 Bispecific Antibody AK132 for the First Time at SITC Annual Meeting
HONG KONG , Nov. 7, 2024 /PRNewswire/ -- At the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), held in Houston, USA, from November 6 - 10, Akeso Biopharma (9926. HK) presented the mechanism of action (MOA) research findings of its innovative bispecific antibody, AK132, targeting both Claudin18.2 (CLDN18.2) and CD47.
prnewswire.com
- 1 week ago
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Less frequent IV dosing with nemvaleukin in patients with select advanced solid tumors, including ovarian cancer and mucosal melanoma, showed tumor site-specific pharmacodynamic activity and immune activation
globenewswire.com
- 1 week ago
Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting
Preliminary data demonstrate durable and dose-dependent T cell responses targeting KRAS mutations and induced responses to patient-specific neoantigens
globenewswire.com
- 1 week ago
Strong Evidence of AU-007's Anti-Tumor Activity in Advanced Solid Tumor Cancers Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class IL-2 therapeutics, today shared positive results from its Phase 1/2 dose escalation and cohort expansion study of AU-007. The data will be presented in a poster session at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting in Houston, Texas. Preliminary Phase 2 data reveal that a combination of AU-007 and low-dose,.
businesswire.com
- 1 week ago
8. Profile Summary
SITE Centers Corp. SITC
COUNTRY
US
INDUSTRY
REIT - Retail
MARKET CAP
$ 819 M
Dividend Yield
4.87%
Description
SITE Centers is an owner and manager of open-air shopping centers that provide a highly-compelling shopping experience and merchandise mix for retail partners and consumers. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Contact
3300 Enterprise Parkway, Beachwood, OH, 44122
https://www.sitecenters.com
IPO Date
Feb. 2, 1993
Employees
220
Officers
Mr. Jeffrey Scott
SVice President & Chief Accounting Officer
Mr. John M. Cattonar
Executive Vice President, Chief Investment Officer & Director
Mr. Kevin Jones
Regional Leasing Manager
Mr. Dale K. Johnson
Vice President & Corporate Controller
Mr. Gerald R. Morgan Jr.
Executive Vice President, Chief Financial Officer & Treasurer
Mr. Francis X. Gonzalez
Vice President of Property Management for PR
Mr. Aaron M. Kitlowski J.D.
Executive Vice President, General Counsel & Corporate Secretary
Mr. Edward T. Sullivan
Vice President of Property Management - Eastern Region
Ms. Stephanie Ruys de Perez
Vice President of Capital Markets
Mr. David R. Lukes
President, Chief Executive Officer & Director